title: Inhaled nitric oxide therapy for secondary pulmonary hypertension with hypertrophic obstructive cardiomyopathy and severe kyphoscoliosis.
authors: Yusuke
authors: Y
authors: Hosokawa
authors: Takeshi
authors: T
authors: Yamamoto
authors: Yuto
authors: Y
authors: Yabuno
authors: Keisuke
authors: K
authors: Hara
authors: Toshiyuki
authors: T
authors: Aokage
authors: Keiko
authors: K
authors: Nakazato
authors: Hiroomi
authors: H
authors: Suzuki
authors: Manabu
authors: M
authors: Suzuki
authors: Akira
authors: A
authors: Ueno
authors: Ryo
authors: R
authors: Munakata
authors: Yukichi
authors: Y
authors: Tokita
authors: Eisei
authors: E
authors: Yamamoto
authors: Koichi
authors: K
authors: Akutsu
authors: Hitoshi
authors: H
authors: Takano
authors: Naoki
authors: N
authors: Sato
authors: Morimasa
authors: M
authors: Takayama
authors: Keiji
authors: K
authors: Tanaka
authors: Kyoichi
authors: K
authors: Mizuno
mesh_terms: D000280:Administration, Inhalation; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D007738:Kyphosis / Q000150:complications; D009569:Nitric Oxide / Q000008:administration & dosage*; D012600:Scoliosis / Q000150:complications; D012720:Severity of Illness Index
chemical_list: D009569:Nitric Oxide